← Leaderboards
Sudha Shankar
Indiana Univ-Purdue Univ At Indianapolis
$711,704
Attributed
$711,704
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $314.9K · FY2005–08$500K$375K$250K$125K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$711,704 · 4
By mechanism
K23$382,519 · 1
M01$329,185 · 3
Top collaborators
No co-investigators on record.
Most similar at Indiana Univ-Purdue Univ At Indianapolis
Same institution · by research overlap
- Min You$9,539,242
- Kenneth H. Fife$1,137,888
- Merrill D Benson$1,208,022
- Md Michael Frank$0
- Michael P Dube$3,435,340
Others in their field
Top investigators on “Hiv Infections”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,259,079
- Lawrence Corey · Fred Hutchinson Cancer Center$728,701,834
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$467,263,656
- Judith S. Currier · University Of California Los Angeles$466,447,923
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$398,445,678
Research focus
Hiv InfectionsRosiglitazoneGlucose MetabolismIndinavirDrug Adverse EffectAcute Phase ProteinInsulin Sensitivity /ResistanceLow Density LipoproteinBlood Vessel DisorderClinical ResearchBaseComputer Retrieval Of Information On Scientific Projects DatabaseAdipose TissueEventCell DifferentiationCardiovascular Disorder RiskArginineGlucoseFundingGrantHigh Density LipoproteinsHiv-1CardiacFunctional Disorder
Grant awards (7)
EFFECTS OF HIV-1 PROTEASE INHIBITORS ON GLUCOSE METABOLISM, ADIPOSE TISSUE, A$8,632
M01 · FY2008 · RR · contact PI
EFFECTS OF HIV-1 PROTEASE INHIBITORS ON GLUCOSE METABOLISM, ADIPOSE TISSUE, A$36,208
M01 · FY2007 · RR · contact PI
EFFECTS OF HIV-1 PROTEASE INHIBITORS ON GLUCOSE METABOLISM, ADIPOSE TISSUE, A$284,345
M01 · FY2006 · RR · contact PI
HIV-1 Protease Inhibitors and Vascular Risk$30,570
K23 · FY2006 · AI · contact PI
HIV-1 Protease Inhibitors and Vascular Risk$121,504
K23 · FY2005 · AI
HIV-1 Protease Inhibitors and Vascular Risk$118,751
K23 · FY2004 · AI
HIV-1 Protease Inhibitors and Vascular Risk$111,694
K23 · FY2003 · AI